Zhengye Biotechnology Holding Stock Net Income
| ZYBT Stock | 1.13 0.02 1.74% |
Zhengye Biotechnology's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Zhengye Stock price.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 12.1 M | 11.5 M | |
| Net Income | 13.5 M | 26.3 M | |
| Net Income Per E B T | 0.71 | 0.59 |
Zhengye | Net Income | Build AI portfolio with Zhengye Stock |
Zhengye Biotechnology Holding Company Net Income Analysis
Zhengye Biotechnology's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Zhengye Biotechnology Net Income | 9.7M |
Most of Zhengye Biotechnology's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhengye Biotechnology Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Zhengye Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Zhengye Biotechnology is extremely important. It helps to project a fair market value of Zhengye Stock properly, considering its historical fundamentals such as Net Income. Since Zhengye Biotechnology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zhengye Biotechnology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zhengye Biotechnology's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Zhengye Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Zhengye Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhengye Biotechnology's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhengye Biotechnology could also be used in its relative valuation, which is a method of valuing Zhengye Biotechnology by comparing valuation metrics of similar companies.Zhengye Biotechnology is currently under evaluation in net income category among its peers.
Zhengye Fundamentals
| Return On Equity | -0.0638 | ||||
| Return On Asset | -0.0345 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.46) % | ||||
| Current Valuation | 59 M | ||||
| Shares Outstanding | 47.39 M | ||||
| Shares Owned By Insiders | 91.20 % | ||||
| Shares Owned By Institutions | 0.33 % | ||||
| Number Of Shares Shorted | 30.79 K | ||||
| Price To Book | 1.25 X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 153.74 M | ||||
| Gross Profit | 57.45 M | ||||
| EBITDA | (2.21 M) | ||||
| Total Debt | 86.43 M | ||||
| Book Value Per Share | 0.90 X | ||||
| Short Ratio | 1.17 X | ||||
| Earnings Per Share | (0.06) X | ||||
| Number Of Employees | 277 | ||||
| Market Capitalization | 53.55 M | ||||
| Total Asset | 493.25 M | ||||
| Retained Earnings | 48.15 M | ||||
| Working Capital | 41.66 M | ||||
| Net Asset | 493.25 M |
About Zhengye Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhengye Biotechnology Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhengye Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhengye Biotechnology Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Zhengye Stock Analysis
When running Zhengye Biotechnology's price analysis, check to measure Zhengye Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhengye Biotechnology is operating at the current time. Most of Zhengye Biotechnology's value examination focuses on studying past and present price action to predict the probability of Zhengye Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhengye Biotechnology's price. Additionally, you may evaluate how the addition of Zhengye Biotechnology to your portfolios can decrease your overall portfolio volatility.